Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease

This publication has 30 references indexed in Scilit:

• Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation.
  The Journal of Experimental Medicine, 1994
• Immunoregulatory role of interleukin 10 in rheumatoid arthritis.
  The Journal of Experimental Medicine, 1994
• Tumor necrosis factor-?, interleukin-1?, and interleukin-6 expression in inflammatory bowel disease
  Digestive Diseases and Sciences, 1992
• Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease.
  Gut, 1992
• Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease.
  Gut, 1992
• Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
  The Journal of Experimental Medicine, 1991
• Regulation of Immune Responses by T Cells with Different Cytokine Secretion Phenotypes: Role of a New Cytokine, Cytokine Synthesis Inhibitory Factor (IL10)
  International Archives of Allergy and Immunology, 1991
• Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis.
  Journal of Clinical Investigation, 1990
• Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine
  Clinical and Experimental Immunology, 1990
• Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease.
  Gut, 1989